Dr. Davidson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Lothrop St
Pittsburgh, PA 15213Phone+1 412-623-3205Fax+1 412-623-3210
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1986
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
- Johns Hopkins UniversityResidency, Internal Medicine, 1980 - 1982
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1979 - 1980
- Pennsylvania Hospital of the University of Pennsylvania Health SystemInternship, Internal Medicine, 1979 - 1980
- Wellesley CollegeBA, 1975 - 1979
- Harvard Medical SchoolClass of 1979
Certifications & Licensure
- MD State Medical License 1982 - 2026
- WA State Medical License 2017 - 2026
- PA State Medical License 1979 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow, American College of Physicians
- The Johns Hopkins Women's Medical Alumnae Association Hall of Fame 2015
- Thomas Reutgers Highly Cited Researchers 2014
- Join now to see all
Clinical Trials
- Combination Chemotherapy in Treating Patients With Breast Cancer Start of enrollment: 1997 Sep 01
- Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer Start of enrollment: 2000 May 19
Publications & Presentations
PubMed
- 1014 citationsPrognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemothe...Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobagyi, Robert B. Livingston
The Lancet. Oncology. 2010-01-01 - 143 citationsTrastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trialsRosie Bradley, Jeremy P Braybrooke, Richard Gray, Robert Kerrin Hills, Z Liu
The Lancet. Oncology. 2021-08-01 - 452 citationsUpdating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments ReceivedLowell E. Schnipper, Nancy E. Davidson, Dana S. Wollins, Douglas W. Blayney, Adam P. Dicker
Journal of Clinical Oncology. 2016-09-27
Press Mentions
- Study Identifies Molecular Differences Between Primary Breast Cancer and Its MetastasesJanuary 9th, 2023
- Fred Hutch/UW Cancer Consortium Breast Cancer Researchers Receive GrantsNovember 17th, 2022
- Seattle Cancer Care Alliance Clinicians Present New Research at 63rd Annual Meeting of the American Society of HematologyDecember 9th, 2021
- Join now to see all
Grant Support
- Senior LeadershipNational Cancer Institute2010–2011
- Planning And EvaluationNational Cancer Institute2010–2011
- DevelopmentalNational Cancer Institute2010–2011
- Cancer Center Support GrantNational Cancer Institute2010–2011
- Exploiting Epigenetic Alterations In BCNational Cancer Institute2006–2010
- Career Development ProgramNational Cancer Institute2006–2010
- Administration CoreNational Cancer Institute2006–2010
- Cancer Center SupportNational Cancer Institute2008–2009
- Spore In Breast CancerNational Cancer Institute2000–2008
- Use Of Demethylating And Histone Deacetylating AgentsNational Cancer Institute2000–2002
- Core--CommunicationNational Cancer Institute2000–2002
- DNA Methylation As A Determinant Of Breast CancerNational Cancer Institute1998–2002
- New Therapeutic Approaches For Breast CancerNational Cancer Institute1995–1998
- Development Of Breast Cancer ProgramNational Cancer Institute1994–1997
- Development Of Breast Cancer ProgramNational Cancer Institute1994
- Programmed Cell Death In Human Breast Cancer CellsNational Cancer Institute1992–1993
- Epidermal Growth Factor Receptor In Human Breast CancerNational Cancer Institute1989–1993
Professional Memberships
- Member
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: